Why does Newsweed cover global and legal cannabis news?
Faced with the non-existence of information on Cannabis in France, Newsweed chose in 2015 to take up the challenge of dealing with its news, not out of proselytism, but out of a concern for objectivity and transparency on this complex, multi-dimensional subject. We cover all topics related to the plant.
Latest legalization trends : Cannabis regulation is a global issue. Processing and analyzing the latest cannabis legal news helps to understand the evolving legal landscape and its implications for all the players involved, from governments, to businesses, to consumers.
Its social and cultural impact: Writing about cannabis news also provides an opportunity to discuss its role in society, including its benefits, risks and controversies. This coverage can contribute to an informed public discourse and to debates that are more factual than dogmatic.
Economic outlook : A cannabis industry exists today, impacting economies around the world. We help to better understand market trends, investment opportunities, job creation and economic development in regions where cannabis is legalized or regulated.
Medical cannabis research: Cannabis has always been used for medical purposes, and its therapeutic properties are now widely recognized. Disseminating information on medical research, treatment options and regulatory developments relating to cannabis and its derivatives also helps to understand the issues at stake for sufferers.
From education to consumers: With the proliferation of cannabis products, consumers need reliable information to make informed choices about consumption, dosage, potency and the safety of legal consumption.
Overall, our Newsweed magazine informs, educates and stimulates dialogue on a complex, multi-faceted issue that has far-reaching implications for individuals, communities and businesses worldwide.
Is Newsweed all about cannabis?
Although we write mainly about cannabis, we also cover other so-called "soft" drugs such as psychedelics, and "hard" drugs such as alcohol, heroin and cocaine.
Psychedelics share a common history with cannabis.
A shared history: Cannabis and psychedelics have been consumed for centuries for spiritual, medicinal and recreational purposes. Ancient civilizations such as the Egyptians, Greeks and Chinese used cannabis for its therapeutic properties, while indigenous cultures in the Americas used psychedelics such as peyote, ayahuasca and psilocybin mushrooms in religious ceremonies.
Identical criminalization: In the 20th century, cannabis and psychedelics came under increasing scrutiny and were eventually criminalized in many parts of the world. Prohibition of these substances was often motivated by moral panic, political agendas and concerns about their perceived negative effects on society.
Similar counter-cultural movements : Cannabis and psychedelics were associated with counter-cultural movements in the 1960s and 1970s. These substances were embraced by groups advocating social change, spiritual exploration and personal liberation. The cultural significance of cannabis and psychedelics during this period influenced public perceptions and shaped the trajectory of drug policy.
Comparable medical research: Despite their illegal status, cannabis and psychedelics have been the subject of scientific research exploring their potential therapeutic benefits. In recent years, there has been renewed interest in studying these substances in the context of pathologies such as chronic pain, post-traumatic stress disorder (PTSD), depression and anxiety. This research has contributed to a reassessment of their medical potential, and is influencing the evolution of regulatory attitudes.
The same regulatory challenges: Despite growing acceptance and legalization in some regions, cannabis and psychedelics continue to face regulatory challenges. Issues such as inconsistent laws, stigmatization, barriers to medical access, and concerns about abuse and addiction are shared between these substances.